Table 1.
Delta (0.5–4 Hz) | Theta (4–10 Hz) | Alpha (10–15 Hz) | Beta (15–25 Hz) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | |||||
Treatment | F(1,180) = 11.42 | * | 0.0009 | F(1,180) = 4.188 | * | 0.0422 | F (1, 180) = 20.95 | * | <0.0001 | F (1, 180) = 2.329 | ns | 0.1288 |
Time Point | F(9,180) = 0.5377 | ns | 0.8457 | F(9,180) = 0.2997 | ns | 0.9741 | F (9, 180) = 1.504 | ns | 0.1495 | F (9, 180) = 1.566 | ns | 0.1285 |
Interaction | F(9,180) = 2.961 | * | 0.0026 | F(9,180) = 2.481 | * | 0.0108 | F (9, 180) = 1.189 | ns | 0.3047 | F (9, 180) = 1.43 | ns | 0.1782 |
Sidak's multiple comparisons test |
Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | ||||
Recovery 1 | * | <0.0001 | Recovery 1 | * | <0.0001 | Recovery 1 | ns | 0.8837 | Recovery 1 | * | 0.0033 | |
Recovery 2 | ns | 0.1898 | Recovery 2 | ns | 0.7652 | Recovery 2 | ns | 0.9060 | Recovery 2 | ns | >0.9999 | |
Recovery 3 | ns | 0.9459 | Recovery 3 | ns | >0.9999 | Recovery 3 | ns | 0.9060 | Recovery 3 | ns | >0.9999 | |
Recovery 4 | ns | 0.9986 | Recovery 4 | ns | >0.9999 | Recovery 4 | ns | 0.7420 | Recovery 4 | ns | >0.9999 | |
Recovery 5 | ns | 0.9874 | Recovery 5 | ns | >0.9999 | Recovery 5 | ns | 0.7061 | Recovery 5 | ns | 0.9859 | |
Recovery 6 | ns | >0.9999 | Recovery 6 | ns | >0.9999 | Recovery 6 | ns | 0.4399 | Recovery 6 | ns | >0.9999 | |
Recovery 7 | ns | 0.9932 | Recovery 7 | ns | 0.9761 | Recovery 7 | ns | 0.5824 | Recovery 7 | ns | >0.9999 | |
Recovery 8 | ns | >0.9999 | Recovery 8 | ns | >0.9999 | Recovery 8 | ns | 0.3532 | Recovery 8 | ns | 0.9989 | |
Recovery 9 | ns | >0.9999 | Recovery 9 | ns | >0.9999 | Recovery 9 | * | 0.0319 | Recovery 9 | ns | >0.9999 | |
Recovery 10 | ns | >0.9999 | Recovery 10 | ns | >0.9999 | Recovery 10 | ns | 0.7925 | Recovery 10 | ns | >0.9999 |
Two-way ANOVA | Low Gamma (25–55 Hz) | Medium Gamma (65–125 Hz) | High Gamma (125–175 Hz) | Ultra-High Gamma (185–250 Hz) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | F(DFn, DFd) | p-value | |||||
Treatment | F (1, 180) = 122.3 | * | <0.0001 | F (1, 180) = 60.65 | * | <0.0001 | F (1, 180) = 49.38 | * | <0.0001 | F (9, 180) = 1.938 | * | 0.0492 |
Time Point | F (9, 180) = 10.61 | * | <0.0001 | F (9, 180) = 8.266 | * | <0.0001 | F (9, 180) = 4.846 | * | <0.0001 | F (9, 180) = 0.9208 | ns | 0.5083 |
Interaction | F (9, 180) = 5.305 | * | <0.0001 | F (9, 180) = 2.787 | * | 0.0044 | F (9, 180) = 3.06 | * | 0.0020 | F (1, 180) = 3.58 | * | 0.0601 |
Sidak's multiple comparisons test |
Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | Saline vs Ketamine | p-value | ||||
Recovery 1 | * | <0.0001 | Recovery 1 | * | <0.0001 | Recovery 1 | ns | 0.7918 | Recovery 1 | ns | 0.2143 | |
Recovery 2 | * | <0.0001 | Recovery 2 | * | <0.0001 | Recovery 2 | * | <0.0001 | Recovery 2 | ns | 0.8167 | |
Recovery 3 | * | <0.0001 | Recovery 3 | * | 0.0167 | Recovery 3 | * | <0.0001 | Recovery 3 | ns | >0.9999 | |
Recovery 4 | * | 0.0007 | Recovery 4 | ns | 0.4190 | Recovery 4 | ns | 0.0575 | Recovery 4 | ns | 0.9998 | |
Recovery 5 | * | 0.0010 | Recovery 5 | ns | 0.0645 | Recovery 5 | ns | 0.0575 | Recovery 5 | ns | >0.9999 | |
Recovery 6 | ns | 0.1676 | Recovery 6 | ns | 0.9671 | Recovery 6 | ns | 0.8743 | Recovery 6 | ns | >0.9999 | |
Recovery 7 | ns | 0.3230 | Recovery 7 | ns | 0.4864 | Recovery 7 | ns | 0.6089 | Recovery 7 | ns | 0.9998 | |
Recovery 8 | ns | 0.4702 | Recovery 8 | ns | 0.3560 | Recovery 8 | ns | 0.9896 | Recovery 8 | ns | 0.9998 | |
Recovery 9 | ns | 0.9088 | Recovery 9 | ns | 0.1643 | Recovery 9 | ns | 0.9212 | Recovery 9 | * | 0.0200 | |
Recovery 10 | ns | >0.9999 | Recovery 10 | ns | 0.9999 | Recovery 10 | ns | >0.9999 | Recovery 10 | ns | 0.6067 |
Two-way ANOVA with Sidak’s multiple comparisons test.
P-value <0.05 considered significant (*) different;
ns: non-significant; vs: versus.